TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
RANI

Rani Therapeutics Holdings Inc

Healthcare · Biotechnology

0.767$ -1.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement RANI
Line item 2019 2020 2021 2022 2023 2024 2025
– -52.8% +488.1% -100.0% – – +58.9%
– – – – -37.3% – –
– -52.8% +488.1% -148.3% – – -28.7%
– -51.0% +119.9% +38.2% +8.2% -32.7% -24.3%
– +43.2% +460.9% -3.6% -1.4% -9.6% -17.6%
– -39.4% +219.4% +16.8% +2.9% -16.8% -28.2%
– – – – – – –
– +1,140.0% +275.8% +129.8% +374.8% -1.0% -42.6%
– – – – – – –
– +250.0% +17.1% +70.7% -48,547.1% – –
– – – – – – –
– – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?